跳至主要内容
临床试验/NCT00182221
NCT00182221已完成3 期

A Cohort Study Evaluating the Safety of a Diagnostic Strategy Involving D-Dimer Testing in Patients With Suspected Pulmonary Embolism

McMaster University4 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2003年8月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
1,000
试验地点
4
主要终点
Venousthromboembolism

研究概览

简要总结

To determine whether D-Dimer testing, using the MDA D-Dimer assay, can be used to simplify the diagnostic process for pulmonary embolism (PE). This will be assessed by performing a cohort study in 1000 patients with suspected PE.

To ascertain if an MDA D-Dimer result of less than 0.75 ug/mL FEU obviates the need for further testing and therapy in patients with suspected PE.

详细描述

Prospective cohort study of 1000 patients in which those with a negative D-Dimer result undergo no further testing and are followed for 3 months for venous thromboembolism. Patients with a positive D-Dimer undergo standardized testing.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age 18 years or older
  • •Suspected PE

排除标准

  • •Treatment with full-dose anticoagulants for 24 hours or more OR an ongoing requirement for anticoagulants
  • •Other tests for PE performed prior to eligibility assessment (e.g.other D-Dimer, V/Q scan, pulmonary angiogram, spiral CT, compression ultrasound, venogram).
  • •Cardiorespiratory instability requiring immediate performance of other tests to diagnose or exclude PE (i.e. inability to wait 30-60 minutes for MDA D-Dimer result)
  • •Comorbid condition limiting survival to less than three months
  • •Patient has been asymptomatic for seven days prior to presentation
  • •Current pregnancy
  • •Contraindication to contrast (e.g., allergy, renal failure).
  • •Geographic in accessibility which precludes follow-up
  • •Presence of central venous catheter (permanent or temporary, including PICC line) at the time of eligibility assessment

结局指标

主要结局

Venousthromboembolism

时间窗: 3 months

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (4)

Loading locations...

相似试验